CHEORS experienced clinical teams develop dossiers to support product approval, registration and licensing. CHEORS is skilled in developing Global Value Dossiers as well as AMCP dossiers. The Global Value Dossiers (GVDs) detail clinical, economic, and humanistic information as well as a comprehensive disease backgrounder with studies and evidence supporting the new product. At completion the GVD will provide an informed and convincing value proposition that pharmaceutical companies can use to demonstrate the comparative benefit of their product to payers and HTA organizations. The graphic below illustrates the questions that the GVD will answer:
CHEORS helps our clients present value messages and supporting evidence to HTA organizations, payers and internal audiences to facilitate product payment, reimbursement, and worldwide launch. This enables our clients to execute a robust global product launch in multiple markets to maximize product access.